• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Life Sciences British Columbia

  • Newsletters |
  • Members Area |
  • Contact
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2023 Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
    • BC Labour Market Study
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
    • Volunteering
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login
Home » All News » Northview Congratulates Portfolio Company Perimeter Medical Imaging AI Inc. on FDA Breakthrough Device Designation

All News

  • Member News
  • Industry News
  • LSBC in The News
Member News

Northview Congratulates Portfolio Company Perimeter Medical Imaging AI Inc. on FDA Breakthrough Device Designation

April 16, 2021
Northview LifeSciences

Northview Lifesciences would like to congratulate Perimeter on their FDA Breakthrough Device Designation for the Optical Coherence Tomography (OCT) Imaging System with ImgAssist AI. The OCT Imaging System offers real time intra-operative evaluation of breast cancer tumor margins during lumpectomies and will give surgeons tomographical confirmation of cancer removal. The goal of the FDA Breakthrough Device Program is to allow timely access to effective treatment and medical devices by speeding up development, assessment, and review. This designation will potentially offer Perimeter’s medical technology a swifter development pathway from clinical validation through to the final stages of development and expedite it’s availability to market and patient use.

Perimeter Official Press Release

Northview Lifesciences – Advancing the Business of Science

Primary Sidebar

  • Category:

  • Sector:

  • Archives:

© 2023 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us